Over the past several years, studies involving theranostic nanoparticles have provided several shining examples of where molecular cancer imaging is going. Health Imaging discussed the future of theranostic nanomedicine with Weibo Cai, PhD, the head of the research lab at the University of Wisconsin–Madison, where Cai’s team has taken full inventory of all the triumphs and tribulations of these tiny yet potent structures.
Over the past several years, studies involving theranostic nanoparticles have provided several shining examples of where molecular cancer imaging is going. Health Imaging discussed the future of theranostic nanomedicine with Weibo Cai, PhD, the head of the research lab at the University of Wisconsin–Madison, where Cai’s team has taken full inventory of all the triumphs and tribulations of these tiny yet potent structures.
Learn more about the study here.